Initial Testing of VS-4718, a novel inhibitor of Focal Adhesion Kinase (FAK), against pediatric tumor models by the Pediatric Preclinical Testing Program

VS-4718 was tested against the PPTP’s in vitro cell line panel and showed a median relative IC(50) of 1.22 µM. VS-4718 was tested in vivo against the PPTP xenograft models using a dose of 50 mg/kg administered by the oral route twice daily for 21 days. VS-4718 induced significant differences in EFS...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Pediatr Blood Cancer
Main Authors: Kurmasheva, Raushan T., Gorlick, Richard, Kolb, E. Anders, Keir, Stephen T., Maris, John M., Lock, Richard B., Carol, Hernan, Kang, Jiarong Min, Reynolds, C. Patrick, Wu, Jianrong, Houghton, Peter J., Smith, Malcolm A.
Format: Artigo
Jezik:Inglês
Izdano: 2016
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5578428/
https://ncbi.nlm.nih.gov/pubmed/27786412
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.26304
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki